Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer

NCT00986206 · clinicaltrials.gov ↗

COMPLETED

Status

525

Enrollment

OTHER

Sponsor class

Conditions

brca1 Mutation Carrier
brca2 Mutation Carrier
Ovarian Cancer

Interventions

DIAGNOSTIC_TEST: Biomarker LPA and HE4

Sponsor

Women and Infants Hospital of Rhode Island